Article
Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome
2023-08-23
Abstract excerpt
The gut and local esophageal microbiome progressively shift from healthy commensal bacteria to inflammatory-linked pathogenic bacteria in patients with gastroesophageal reflux disease, Barrett’s esophagus and esophageal adenocarcinoma (EAC). However, mechanisms by which microbial communities and metabolites contribute to reflux-driven EAC remain incompletely understood and challenging to target. Herein, we utilize...
Topics
Open a Topic to create a Post that cites this publication.
- Cancer Immunotherapy and Biomarkers
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Esophageal and GI Pathology
- Esophageal Cancer Research and Treatment
- Gastric Cancer Management and Outcomes
- Gastroesophageal reflux and treatments
- Helicobacter pylori-related gastroenterology studies
- Pancreatic and Hepatic Oncology Research
Identifiers and source
- Literature Corpus work
- d9062c71-d6c7-57b6-b067-66491811e452
- DOI
- 10.1101/2023.08.22.554315
